Synthesis, Characterization, and Evaluation of Antioxidant, Anti‐Inflammatory, and Antimicrobial Activities of Zinc Oxide Nanoparticles Using Adiantum capillus‐veneris L. Leaf Extract
Source abstract
Abstract
Abstract Due to its unique properties and advantageous traits, zinc oxide has garnered significant attention in recent years for the green synthesis of ZnO nanoparticles (ZnO‐NP). This paper is focused on the synthesis of ZnO‐NPs mediated by Adiantum capillus‐veneris L. leaf extract and assesses their potential biological activities. In this study, ZnO‐NP is synthesized using A. capillus‐veneris L. leaf extract. The synthesized nanoparticles are characterized using, UV–vis spectroscopy, energy‐dispersive X‐ray spectroscopy (EDX), (SEM) scanning electron microscopy, X‐ray diffraction (XRD), and Fourier transform infrared (FT‐IR) spectrophotometry. The antibacterial, antifungal, anti‐inflammatory, and antioxidant properties of the formulated ZnO‐NPs are also inspected. The UV–vis, XRD, SEM, EDX, and FTIR confirmed the formation and purity of synthesized ZnO‐NPs. The ZnO‐NPs exhibit efficient antimicrobial potency against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Aspergillus niger, and Aspergillus fumigatus. Gram‐positive bacteria, particularly S. aureus, are more susceptible to ZnO‐NPs, with the largest inhibition zone of 32 mm. In contrast, E. coli and P. aeruginosa display smaller inhibition zones of 25 and 27 mm respectively. Anti‐inflammatory tests show that ZnO‐NPs have a significant anti‐inflammatory effect against egg albumin and bovine serum albumin denaturation, possess low toxicity on erythrocytes, and are highly hemocompatible.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Moringa oleifera research and applications · Nanoparticles: synthesis and applications · Essential Oils and Antimicrobial Activity
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biology Faculty of Science Soran University Kurdistan 44008 Iraq
Scientific Research Centre Soran University Kurdistan 44008 Iraq
SISAF Drug Delivery Nanotechnology Ulster University Belfast BT37 0QB UK
References (62)
Show source-provided references
1. 10.1016/j.eti.2022.10233610.1016/j.eti.2022.102336 ↗
2. Shnawa B. H. · 2021 · 180
3. 10.3390/cancers1318457010.3390/cancers13184570 ↗
4. 10.3390/nano1318257310.3390/nano13182573 ↗
5. 10.1016/j.inoche.2024.11208610.1016/j.inoche.2024.112086 ↗
6. 10.1186/s11671-020-03418-610.1186/s11671-020-03418-6 ↗
7. 10.3390/molecules2616471010.3390/molecules26164710 ↗
8. 10.1016/j.ecoenv.2020.11115810.1016/j.ecoenv.2020.111158 ↗
9. 10.1016/j.bcab.2023.10276510.1016/j.bcab.2023.102765 ↗
10. 10.1007/s43450-021-00179-w10.1007/s43450-021-00179-w ↗
11. 10.1517/17425247.2010.50256010.1517/17425247.2010.502560 ↗
12. 10.1016/j.phanu.2022.10028810.1016/j.phanu.2022.100288 ↗
13. 10.1016/j.jece.2019.10346810.1016/j.jece.2019.103468 ↗
14. 10.1039/D1RA09152B10.1039/D1RA09152B ↗
15. Ansari R. · JASR · 2012 · 3 · 15
16. 10.1590/S0102-695X201300500002310.1590/S0102-695X2013005000023 ↗
17. 10.1177/0885328223120723610.1177/08853282231207236 ↗
18. 10.1016/j.sjbs.2022.10355010.1016/j.sjbs.2022.103550 ↗
19. 10.1007/s42247-021-00264-910.1007/s42247-021-00264-9 ↗
20. Shnawa B. H. · Pak Vet J · 2022 · 42 · 517
21. 10.22401/ANJS.26.2.1010.22401/ANJS.26.2.10 ↗
22. Xu J. · Journal of Engineered Fibers and Fabrics · 2021 · 16
23. Karzan K. · Eurasian j, eng sci technol · 2017 · 3 · 82
24. 10.1007/s10534-022-00391-810.1007/s10534-022-00391-8 ↗
25. 10.1016/S0367-326X(99)00030-110.1016/S0367-326X(99)00030-1 ↗
26. 10.1186/2008-2231-20-7610.1186/2008-2231-20-76 ↗
27. 10.1371/journal.pone.013555810.1371/journal.pone.0135558 ↗
28. 10.3390/biomedicines604010710.3390/biomedicines6040107 ↗
29. Ezzi A. · J microbiol exp · 2017 · 4
30. 10.1021/jp046414m10.1021/jp046414m ↗
31. Moges Tsega Y. · J. Nanomater. · 2023 · 2023
32. 10.22270/jddt.v8i5-s.206510.22270/jddt.v8i5-s.2065 ↗
33. 10.3389/fpls.2023.110818610.3389/fpls.2023.1108186 ↗
34. 10.3390/antiox1204078410.3390/antiox12040784 ↗
35. 10.1016/j.jksus.2016.10.00210.1016/j.jksus.2016.10.002 ↗
36. 10.1016/j.surfin.2021.10100010.1016/j.surfin.2021.101000 ↗
37. 10.3390/app1010362010.3390/app10103620 ↗
38. 10.3389/fmolb.2022.99166910.3389/fmolb.2022.991669 ↗
39. 10.1016/j.btre.2021.e0059510.1016/j.btre.2021.e00595 ↗
40. 10.1038/s41598-022-06657-y10.1038/s41598-022-06657-y ↗
41. 10.1155/2015/72065410.1155/2015/720654 ↗
42. 10.1016/j.lwt.2017.10.00810.1016/j.lwt.2017.10.008 ↗
43. 10.1016/j.jcis.2016.03.02110.1016/j.jcis.2016.03.021 ↗
44. 10.1021/acs.chemrev.0c0058710.1021/acs.chemrev.0c00587 ↗
45. Navale G. R. · JSM Nanotechnol Nanomed · 2015 · 3 · 1033
46. 10.1016/j.biortech.2010.07.11710.1016/j.biortech.2010.07.117 ↗
47. 10.2147/IJN.S18688810.2147/IJN.S186888 ↗
48. 10.3390/molecules2708248910.3390/molecules27082489 ↗
49. 10.1016/j.matchemphys.2019.05.07510.1016/j.matchemphys.2019.05.075 ↗
50. 10.1016/j.apsoil.2018.09.01210.1016/j.apsoil.2018.09.012 ↗
51. Olugbami J. · Afr J Med Med Sci · 2014 · 43 · 101
52. 10.1007/s10876-020-01962-w10.1007/s10876-020-01962-w ↗
53. 10.1016/j.colsurfb.2013.06.04110.1016/j.colsurfb.2013.06.041 ↗
54. 10.1016/j.sciaf.2022.e0145210.1016/j.sciaf.2022.e01452 ↗
55. 10.1061/JHTRBP.HZENG-121710.1061/JHTRBP.HZENG-1217 ↗
56. Khodaie L. · Jundishapur J Nat Pharm Prod · 2015 · 10
57. 10.1155/2023/882576210.1155/2023/8825762 ↗
58. 10.1007/s00203-023-03549-110.1007/s00203-023-03549-1 ↗
59. 10.3390/ijms2402147410.3390/ijms24021474 ↗
60. 10.1007/s10876-019-01571-210.1007/s10876-019-01571-2 ↗
61. 10.1166/jnn.2015.1031910.1166/jnn.2015.10319 ↗
62. 10.1016/j.pbb.2004.08.01210.1016/j.pbb.2004.08.012 ↗